UNION KOREA PHARM

The current price of 080720 is 5670 KRW — it has decreased by 0.18% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange UNION KOREA PHARM stocks are traded under the ticker 080720.

080720 stock is 2.87% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is UNION KOREA PHARM there?

Yes, you can track UNION KOREA PHARM financials in yearly and quarterly reports right on TradingView.

080720 stock has fallen by 1.73% compared to the previous week, the month change is a 9.88% rise, over the last year UNION KOREA PHARM has showed a 7.50% decrease.

080720 net income for the last quarter is ‪−12.25 B‬ KRW, while the quarter before that showed ‪−3.70 B‬ KRW of net income which accounts for −231.05% change. Track more UNION KOREA PHARM financial stats to get the full picture.

No, 080720 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 080720 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNION KOREA PHARM stock right from TradingView charts — choose your broker and connect to your account.

080720 reached its all-time high on Nov 12, 2020 with the price of 25500 KRW, and its all-time low was 4210 KRW and was reached on Oct 30, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 205.00 employees. See our rating of the largest employees — is UNION KOREA PHARM on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNION KOREA PHARM technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNION KOREA PHARM stock shows the sell signal. See more of UNION KOREA PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNION KOREA PHARM EBITDA is ‪−1.34 B‬ KRW, and current EBITDA margin is −2.13%. See more stats in UNION KOREA PHARM financial statements.